Mairs & Power Inc Amgen Inc Transaction History

Mairs & Power Inc

$10.5 Billion
Q3 2024

A detailed history of Mairs & Power Inc transactions in Amgen Inc stock. As of the latest transaction made, Mairs & Power Inc holds 5,948 shares of AMGN stock, worth $1.57 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,948

Previous 5,950 0.03%

Holding current value

$1.57 Million

Previous $1.86 Million 3.07%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $618 - $674	-2 Reduced 0.03%	5,948 $1.92 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $350,771 - $426,278	-1,335 Reduced 18.33%	5,950 $1.86 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $48,396 - $58,420	-180 Reduced 2.41%	7,285 $2.07 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $2,557 - $2,884	-10 Reduced 0.13%	7,465 $2.15 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $35,421 - $43,976	-162 Reduced 2.12%	7,475 $2.01 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $239,339 - $283,014	-1,117 Reduced 12.76%	7,637 $1.7 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $32,739 - $39,904	-145 Reduced 1.63%	8,754 $2.12 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $8,245 - $10,476	-36 Reduced 0.4%	8,899 $2.34 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $13,018 - $14,682	-58 Reduced 0.64%	8,935 $2.01 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $69,443 - $77,278	301 Added 3.46%	8,993 $2.19 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $27,408 - $30,321	125 Added 1.46%	8,692 $2.1 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $12,529 - $14,338	-63 Reduced 0.73%	8,567 $1.93 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $53,067 - $62,175	250 Added 2.98%	8,630 $1.84 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $17,518 - $19,435	-75 Reduced 0.89%	8,380 $2.04 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $7,766 - $9,051	-35 Reduced 0.41%	8,455 $2.1 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $7,573 - $9,018	35 Added 0.41%	8,490 $1.95 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $17,598 - $19,571	75 Added 0.89%	8,455 $2.15 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $75,684 - $97,280	-400 Reduced 4.56%	8,380 $2.02 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $50,010 - $58,623	-300 Reduced 3.3%	8,780 $1.62 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $43,951 - $49,542	-243 Reduced 2.61%	9,080 $1.73 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $44,600 - $52,062	-250 Reduced 2.61%	9,323 $1.82 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $119,697 - $134,942	-646 Reduced 6.32%	9,573 $1.98 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $44,999 - $50,544	271 Added 2.72%	10,219 $1.89 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $336,318 - $393,030	1,985 Added 24.93%	9,948 $1.7 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $28,019 - $31,305	-166 Reduced 2.04%	7,963 $1.39 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1.36 Million - $1.55 Million	8,129	8,129 $1.52 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.

Account